Carpal Tunnel Syndrome Carpal Tunnel Syndrome,hand surgery,regenerative medicine, Platelet-Rich Plasma.
Conditions
Interventions
Sponsors
Naito Kiyohito
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Carpal tunnel syndrome. 2) Carpal tunnel syndrome numbness and pain relief can be expected. 3) Have good systemic condition. 4) Number of platelet is over 1x10^5 /microliter. 5) 18 years and older. 6) Other,the investigator believes makes him/her suitable for participation in this clinical study.
Exclusion criteria
Exclusion criteria: 1) Have a history of Complicate malignant tumor. 2) Patients with malignant tumor, precancerous lesion, or findings suspected of these on the same side as curpal tunnel syndrome. 3) Under 18 years of old. 4) Pregnancy, during breastfeeding, or possibility of pregnancy. 5) Other,the investigator believes makes him/her unsuitable for participation in the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the safety of regenerative medical technology using the cell processing products. If below (1) or (2) occurs, at that point we will consider whether to continue enrollment in the study, treatment, or whole study. (1) If one or more adverse events grade 3 or higher of the Common Terminology Criteria for Adverse Events suspected to be related to the provision of regenerative medicine v5.0 Japanese translation JCOG version (abbreviation: CTCAE v5.0 -JCOG) occur. (2) In accordance with the Act on Securing the Safety of Regenerative Medicine, etc., if a "disease, injury, death, or infectious disease suspected to be caused by the provision of regenerative medicine, etc., listed in the regenerative medicine provision plan" occurs. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Analgesic effect of this treatment The course of pain after treatment will be evaluated during the observation period related to safety, which was set as the primary outcomes (in this clinical study, evaluation was performed 4 weeks after treatment). VAS for pain evaluation is planned to be analyzed using a paired-t test. 2.Patient subjective evaluation The satisfaction with treatment will be evaluated using a questionnaire. | — |
Countries
Japan
Contacts
Public ContactKiyohito Naito
Juntendo Hospital, Juntendo university school of medicine
Outcome results
None listed